Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EBOS Group Limited ( (AU:EBO) ) has shared an announcement.
EBOS Group Limited announced a change in the director’s interest, with Stuart McLauchlan acquiring 56 additional ordinary shares through a dividend reinvestment plan, increasing his total holdings to 3,686 shares. This change reflects a minor adjustment in the company’s director shareholding, which may have minimal immediate impact on the company’s operations but indicates continued confidence in the company’s performance.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a range of products and services. The company focuses on the distribution and wholesaling of healthcare, medical, and pharmaceutical products, as well as animal care products, serving markets in Australia and New Zealand.
Average Trading Volume: 139,855
Technical Sentiment Signal: Sell
Current Market Cap: A$5.28B
See more insights into EBO stock on TipRanks’ Stock Analysis page.